Decibel Therapeutics Inc 's ROA from the second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Decibel Therapeutics Inc 's ROA in the second quarter of 2023?
Decibel Therapeutics Inc recorded a cumulative net loss of $-63 million during 12 months ending in the second quarter of 2023, resulting in a negative return on assets (ROA) of -53.89%.

However, within the Healthcare sector 741 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2023 quarter, so far to 4650, from total ROA ranking in the first quarter of 2023 at 4671.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter
Y / Y Total Assets Change	-40.37 %	-34.83 %	-33.53 %	-9.91 %	-6.45 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-63	-62	-63	-60	-60
Return On Assets (TTM)	-53.89 %	-46.63 %	-42.47 %	-36.59 %	-35.97 %
DBTX's Total Ranking	# 4650	# 4671	# 5303	# 4606	# 4748
Total Assets (TTM) in million	94	110	123	142	158
Seq. Total Assets Change	-14.55 %	-10.47 %	-13.28 %	-10.11 %	-6.61 %
Seq. Net Income Change	-	-	-	-	-

DBTX's 5 Years Annual ROA >> Back to DBTX Management Effectiveness >> Compare DBTX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 334
Sector	# 742
Overall	# 4554

Return On Assets Statistics
High	Average	Low
-26.79 %	-38.57 %	-53.89 %
(Dec 31 2021)		(Jun 30 2023)

Financial Statements
Decibel Therapeutics Inc 's Assets	$ 94 million	DBTX's Balance sheet
Decibel Therapeutics Inc 's Income	$ -18 million	Quarterly DBTX's Income Statement
DBTX's Income by Division		See DBTX's Income by Division

Annual Return On Assets	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	FY	FY	FY
Y / Y Total Assets Change	-33.12 %	-	-	-	-
Total Assets in million	123	184	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-63	-52	0	0	0
Annual Return On Assets	-51.07 %	-28.09 %	-	-	-

DBTX's 5 Years Annual ROA >> Back to DBTX Management Effectiveness >> Compare DBTX ROA to its Competitors

More Return On Assets Ratios
DBTX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
DBTX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for DBTX's Competitors
Subscribers only: Roa for Decibel Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for DBTX's Customers

You may also want to know
DBTX's Roi	DBTX's Inventory Turnover Ratio	DBTX's Growth Rates	DBTX's Dividend Comparisons
	DBTX's Profitability Ratios	DBTX's Asset Turnover Ratio	DBTX's Dividend Growth
DBTX's Roe	DBTX's Valuation Ratios	DBTX's Financial Strength Ratios	DBTX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2023, within Healthcare Sector

ROA

Date modified: 2026-08-29T17:43:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.